One winter's night in 1976, over 20 million people in Britain watched John Curry skate to Olympic glory on an ice rink in Austria. Many millions more watched around the world. Overnight he became one of the most famous men on the planet. He was awarded the OBE. He was chosen as BBC Sports Personality of the Year. Curry had changed ice skating from marginal sport to high art. And yet the man was - and would always remain - an absolute mystery to a world that had been dazzled by his gift. Surely, men's skating was supposed to be Cossack-muscular, not sensual and ambiguous like this. Curry himself was an often-tortured man of labyrinthine complexity. For the first time, Alone untangles the extraordinary web of his toxic, troubled, brilliant - and short - life. It is a story of childhood nightmares, furious ambition, sporting genius, lifelong rivalries, homophobia, Cold War politics, financial ruin and deep personal tragedy. Alone reveals the restless, impatient, often dark soul of a man whose words could lacerate, whose skating invariably moved audiences to tears, and who - after succumbing to AIDS, as so many of his fellow artists and friends did - died of a heart attack aged just 44. 1. Language: English. Narrator: Graeme Malcolm. Audio sample: http://samples.audible.de/bk/adbl/020352/bk_adbl_020352_sample.mp3. Digital audiobook in aax.
High Quality Content by WIKIPEDIA articles! The International AIDS Society (IAS) is the world's leading independent association of HIV professionals, with 14,000 members from 190 countries working at all levels of the global response to AIDS. IAS members include researchers from all disciplines, clinicians, public health and community practitioners on the frontlines of the epidemic, as well as policy and programme planners. The International AIDS Society s vision is a global movement of people working together to end the HIV epidemic, applying scientific evidence and best practice at every level of the HIV response. The IAS is the custodian of the biennial International AIDS Conference, which will next be held in Vienna, Austria from 18 to 23 July 2010. The IAS is also the lead organizer of the IAS Conference on HIV Pathogenesis, Treatment and Prevention, which will next be held in .Rome, Italy, from 17- 21 July 2011.
Geoffrey Ball's extraordinary adventure in technology began in the legendary Silicon Valley of California and ultimately led him to the mountains of Austria, where he now lives and continues his work. Even as a child, Ball knew that sign language, conventional hearing aids, and lipreading were not for him, so he decided to find a cure for his deafness. Never letting his disability stand in his way, he became a kind of modern Renaissance man with wide-ranging interests and abilities, all coupled with an undeniable talent for entrepreneurship and invention.Ball introduces us to family and friends, surfing buddies and lab rats, business partners and fellow inventors, computer and Internet legends, the larger-than-life mentor who gave him his start, and the woman who ultimately saved his brainchild. He intersperses insights into technology and business with personal anecdotes and fascinating accounts of successes, failures and near misses along the way.
At the end of the year 2001, representatives of 5 Austrian HIV treatment centres (AKH Vienna, Otto-Wagner-Hospital Vienna, AKH Linz, LKH Innsbruck and LKH Graz West) have founded the „Austrian HIV Cohort Study (AHIVCOS)“. In 2008, two more centres (LKH Salzburg and LKH Klagenfurt) and in 2016 one more centre (Kaiser- Franz-Josef-Hospital Vienna) joined the AHIVCOS. The responsibility for the medical and scientific coordination lies with Robert Zangerle from the Innsbruck Medical University. Aims of Austrian cohort study are: 1) Optimization of patient management 2) HIV surveillance 3) Research projects A special software, the "HIV Patient Management System (HIP)" is used in all centres and has replaced the previous HIV data base in 2005. The input of data is (was) done peripherally in the HIV treatment centres which consistently use the data base for clinical care. The input of laboratory findings is mostly done electronically. Apart from nurses and doctors, additional professional groups are involved in data entry in some centres (social workers, psychologists). Before data can be merged, the cohort participants are made anonymous. Therefore, it is cumbersome to identify cohort participants who are/were treated in more than just one treatment centre. This cannot be done by the use of personal data such as initials, birthday or postal code, but with HIV specific data (date of the HIV test, CD4 cell counts etc.). HIV Patient Management System: Designed as a client-server application, the HIP stores its data in a persistent SQL database. The software is based on the model driven architecture paradigm and has been implemented with Microsoft .NET technology. The company DI Heinz Appoyer (now called network vita) was entrusted with the development of the HIP. The required hardware is provided by the local IT departments in the centres. In terms of data protection the programme fully complies with the Austrian data protection act (DSG 2000, valid since 1.1.2000). Access to the data base in the centres is restricted to authorized users only. On the one hand, the HIP fulfils complex tasks for the clinical management of HIV infected patients, and on the other hand it allows queries and analyses to be performed by the users without restrictions. However, to allow both individual patient management and scientific queries is an enormous challenge which scientific HIV cohorts in other countries have not had to deal with. In Austria, there was no acceptance for a purely scientific data base. While for the clinical patient management the focus is on readability of diagnoses and therapies, creation of medical reports, prescriptions (trade names!), print-out of results etc., scientific queries need precise coding and categorization. Furthermore, the optimization of individual patient management requires an ongoing adjustment to the progress of information technology, whereas purely scientific data bases do not have such technological renewal pressure.
'Failsafe is brilliant, so thoroughly researched, eloquently written and, most of all, so needed. It's a wonderful book. Frightening to read while observing the band-aids and half measures being proposed in the US.' - Peter Cutler, writer and artist, Boston USA 'I am deeply impressed by this holistic treatise, Failsafe. His conclusions are encouraging, to see mother earth and ourselves with the healing hands of a Bodhisattva. A Lotus to him a Buddha to be!' - Axel Traexler, Global Marshall Plan, Austria 'For ten thousand years of the agricultural revolution, humans continued to understand that we were deeply embedded in and utterly dependent on nature because farmers pay attention to weather and climate, winter snow and summer moisture, beneficial insects and plants, etc. Over the past century, humanity has undergone an astonishing transition from rural village inhabitants to big city dwellers where we feel ourselves disconnected and isolated from nature and ensconce the economy as our highest priority. The way we see the world, shapes the way we treat it and if we no longer perceive the planet as our sacred home, but instead, as an economic opportunity, then we will continue to log, mine, dam and degrade the biosphere. In Failsafe, Ian Prattis offers a way to a perceptual transformation that is absolutely critical if we are to find a truly sustainable future.' - David Suzuki, author, environmentalist, host of CBC's The Nature of Things
These two volumes record the scientific and clinical work presented at the VIIth International and 3rd European joint symposium on purine and pyrimidine metabolism in man held at the Bournemouth International Conference Centre, Bournemouth, UK, from 30th June to 5th July 1991. The series of international meetings at three yearly intervals have previously been held initially in 1973 in Israel, then Austria, Spain, the Netherlands, USA and Japan. The European Society for the Study of Purine and pyrimidine Metabolism in Man (ESSPPM) which has its own executive and some finance first met in switzerland in 1987, then in Germany in 1989. The steady evolution of the science in this series of meetings is intellectually satisfying; the subsequent clinical progress is emotionally and economically reassuring. As befits the position of purines and pyrimidines at the centre of biochemistry, there has been steady scientific development into molecular genetics and now onto developmental controls and biochemical pharmacology. The complexities of the immune system are being unravelled but an understanding of the human brain largely eludes us. Laboratory based scientists now predominate over those who work as clinical specialists in VIi rheumatology, immunology, oncology and paediatrics. However, there continue to be major clinical objectives since large sections are concerned with major causes of death like ATP depletion, cancer and now AIDS; the laboratory work is providing clinical solutions.
Geoffrey Ball's extraordinary adventure in technology began in the legendary Silicon Valley of California and ultimately led him to the mountains of Austria, where he now lives and continues his work. Even as a child, Ball knew that sign language, conventional hearing aids, and lipreading were not for him, so he decided to find a cure for his deafness. Never letting his disability stand in his way, he became a kind of modern Renaissance man with wide-ranging interests and abilities, all coupled with an undeniable talent for entrepreneurship and invention. Ball introduces us to family and friends, surfing buddies and lab rats, business partners and fellow inventors, computer and Internet legends, the larger-than-life mentor who gave him his start, and the woman who ultimately saved his brainchild. He intersperses insights into technology and business with personal anecdotes and fascinating accounts of successes, failures and near misses along the way.
This volume presents a selection of contributions from the Fifth Workshop on Informatics and Psychology at Schärding, Austria, May 1986, which focused on 'Visual Aids in Programming'. The lectures give a broad view of the state of the art in this new field of research and development spanning Cognitive Science, Informatics and Ergonomics, which draws its impact from the growing need for a deeper understanding of complex program structures and for better program design. The topics include the visualization of program structures, the discussion of psychological aspects, design problems of visual interfaces, and present implementations.
Hearing loss affects countless millions of people, yet few sufferers even seek help, let alone try to find a cure. This is the story of a man who took on that daunting task and ultimately invented the world's most successful middle ear implant. Geoffrey Ball's adventure in technology began in the legendary Silicon Valley of California, the birthplace of so many innovations that have transformed our world, and ultimately led him to the mountains of Austria, where he now lives and continues his work. Ball's deafness was diagnosed early, but even as a child he knew that sign language and conventional hearing aids were not the answer. Despite his proficiency in lipreading, he wanted more - a better fix. Meanwhile, Ball never let his disability stand in his way. He became a kind of modern Renaissance man with interests that ranged from literature to sports to music, all coupled with an undeniable talent for entrepreneurship and invention. The author introduces us to family and friends, surfing buddies and lab rats, business partners and fellow inventors, computer and Internet legends, a brilliant, larger-than-life mentor who gave him his start, and the woman who ultimately saved his brainchild. He intersperses insights into technology, funding and business acumen with personal, often humorous anecdotes and fascinating accounts of successes, failures and near misses along the way. Today, every hour, somewhere in the world, one of his ground- breaking devices improves the quality of life of a hearing-impaired person. No one is laughing at the deaf boy now, and we haven't heard the last of Geoffrey Ball.